28. He W., Hao J., Dong S., Gao Y., Tao J., Chi H., Flavell R., O'Brien R. L., Born W. K., Craft J., Han J., Wang P., Zhao L., Wu J., Yin Z. Naturally activated V gamma 4 gamma delta T cells play a protective role in tumor immunity through expression of eomesodermin. J. Immunol., 2010, vol. 185, no. 1, pp. 126-133.
29. Jomantaite I., Dikopoulos N., Krцger A., Leithдuser F., Hauser H., Schirmbeck R., Reimann J. Hepatic dendritic cell subsets in the mouse. Eur. J. Immunol., 2004, vol. 34, no. 2, pp. 355-365.
30. Kikuchi A., Nieda M., Koezuka Y., Ishihara S., Ishikawa Y., Tadokoro K., Durrant S., Boyd S., Juji T., Nicol A. In vitro anti-tumour activity of alphagalactosylceramide-stimulated human invariant Valpha24 + NKT cells against melanoma. Br. J. Cancer, 2001, vol. 85, no. 5, pp. 741-746.
31. Knolle P. A., Schmitt E., Jin S., Germann T., Duchmann R., Hegenbarth S., Gerken G., Lohse A. W. Induction of cytokine production in naive CD4(+) T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells. Gastroenterology, 1999, vol. 116, no. 6, pp. 1428-1440.
32. Krummel M. F., Mahale J. N., Uhl L. F. K., Hardison E. A., Mujal A. M., Mazet J. M., Weber R. J., Gartner Z. J., Gйrard A. Paracrine costimulation of IFN-y signaling by integrins modulates CD8 T cell differentiation. Proc. Natl. Acad. Sci. USA, 2018, vol. 115, no. 45, pp. 11585-11590. doi: 10.1073/pnas.1804556115.
33. Leung P. S., Park O., Tsuneyama K., Kurth M. J., Lam K. S., Ansari A. A., Coppel R. L., Gershwin M. E. Induction of primary biliary cirrhosis in guinea pigs following chemical xenobiotic immunization. J. Immunol., 2007, vol. 179, no. 4, pp. 2651-2657.34. Martins E. B., Graham A. K., Chapman R. W., Fleming K. A. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases. Hepatology, 1996, vol. 23. pp. 988-993.
35. Pillai A.B., George T.I., Dutt S., Teo P., Strober S. NKT cells can prevent graft-versushost disease and permit graft antitumor activity after bone marrow transplantation. J. Immunol., 2007, vol. 178, no. 10, pp. 6242-6251.
36. Rangari M. Sinha S., Kapoor D., Mohan J.C., Sarin S.K. Prevalence of autonomic dysfunction in cirrhotic and noncirrhotic portal hypertension. Am. J. Gastroenterol., 2002, vol. 97, no. 3, pp. 707-713.
37. Rogers S. L., Kaufman J. Location, location, location: the evolutionary history of CD1 genes and the NKR-P1/ligand systems. Immunogenetics, 2016, vol. 68, no. 8, pp. 499-513. doi: 10.1007 / s00251-016-0938-6.
38. Said E. A., Al-Reesi I., Al-Riyami M., Al-Naamani K., Al-Sinawi S., Al-Balushi M. S., Koh C. Y., Al-Busaidi J. Z., Idris M. A., Al-Jabri A. A. Increased CD86 but Not CD80 and PD-L1 Expression on Liver CD68+ Cells during Chronic HBV Infection. PLoS One, 2016, vol. 11, no. 6, e0158265. doi: 10.1371/journal.pone.0158265.
39. Schildberg F. A., Hegenbarth S. I., Schumak B., Scholz K., Limmer A., Knolle P. A. Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. Eur. J. Immunol., 2008, vol. 38, no. 4, pp. 957-967.
40. Seino K., Motohashi S., Fujisawa T., Nakayama T., Taniguchi M. Natural killer T cellmediated antitumor i mmune responses and their clinical applications. Cancer Sci., 2006, vol. 97, no. 9, pp. 807-812.
41. Shahine A., Reinink P., Reijneveld J. F., Gras S., Holzheimer M., Cheng T. Y., Minnaard A. J., Altman J. D., Lenz S., Prandi J., Kubler-Kielb J., Branch Moody D., Rossjohn J., Van Rhijn I. A T -cell receptor escape channel allows broad T-cell response to CD1b and membrane phospholipids. Nat. Commun., 2019, vol. 10, no. 1, pp. 56. doi: 10.1038/s41467-018-07898-0.
42. Stetak A., Csermely P., Ullrich A., Kcri G. Physical and functional interactions between protein tyrosine phosphatase a, PI 3-kinase, and PKC5. Biochem. Biophys. Res. Commun., 2001, vol. 288, no. 3, pp. 564-572.
43. Thomson A. W., Knolle P. A. Antigen-presenting cell function in the tolerogenic liver environment. Nat. Rev. Immunol., 2010, vol. 10, no. 11, pp. 753-766. doi: 10.1038 / nri2858.
44. Vinas O., Bataller R., Sancho-Bru P., Ginиs P., Berenguer C., Enrich C., Nicolas J.M., Ercilla G., Gallart T., Vives J., Arroyo V., Rodйs J. Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation. Hepatology, 2003, vol. 38, no. 4, pp. 919-929.
45. Vivier E., Raulet D. H., Moretta A., Caligiuri M. A., Zitvogel L., Lanier L. L., Yokoyama W. M., Ugolini S. Innate or adaptive immunity? The example of natural killer cells. Science, 2011, vol. 331, no. 6013, pp. 44-49. doi: 10.1126/science. 1198687.
46. Wang Y., Du X., Wei J., Long L., Tan H., Guy C., Dhungana Y., Qian C., Neale G., Fu Y. X., Yu J., Peng J., Chi H. LKB1 orchestrates dendritic cell metabolic quiescence and anti-tumor immunity. Cell Res. - 2019. - vol. 29, no. 5, pp. 391-405. doi: 10.1038 / s41422-019-0157-4.
47. Wang Z. Zhang H., Liu R., Qian T., Liu J., Huang E., Lu Z., Zhao C., Wang L., Chu Y. Peyer's patches- derived CD11b+ B cells recruit regulatory T cells through CXCL9 in dextran sulphate sodium-induced colitis. Immunology, 2018, vol. 155, no. 3, pp. 356-366. doi: 10.1111 / imm.12977.
48. Wen L., Ma Y., Bogdanos D. P., Wong F. S., Demaine A., Mieli-Vergani G., Vergani D. Pediatric autoimmune liver diseases: the molecular basis of humoral and cellular immunity. Curr. Mol. Med., 2001, vol. 1, no. 3, pp. 379-389.